Stock 688068 BEIJING HOTGEN BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Beijing Hotgen Biotech Co., Ltd.

Equities

688068

CNE100003P82

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
25.72 CNY -2.91% Intraday chart for Beijing Hotgen Biotech Co., Ltd. -6.47% -37.34%
08/05 Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2024. CI
07/05 Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback announced on February 8, 2024, has closed with 2,893,010 shares, representing 3.24% for CNY 92.02 million. CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 2,189 2,425 7,224 5,606 3,670
Enterprise Value (EV) 1 1,790 2,042 5,172 4,186 3,083
P/E ratio 70 x 21.7 x 3.31 x 5.92 x 132 x
Yield 0.64% 3.85% 4.3% - 0.49%
Capitalization / Revenue 10.4 x 4.72 x 1.35 x 1.58 x 6.78 x
EV / Revenue 8.51 x 3.98 x 0.96 x 1.18 x 5.7 x
EV / EBITDA 37.6 x 14.5 x 1.97 x 3.54 x 458 x
EV / FCF -15.7 x -57.4 x 3.14 x 32.5 x -5.49 x
FCF Yield -6.37% -1.74% 31.8% 3.07% -18.2%
Price to Book 4.52 x 3.27 x 2.54 x 1.63 x 1.09 x
Nbr of stocks (in thousands) 69,037 92,051 92,051 92,051 89,407
Reference price 2 31.71 26.34 78.48 60.90 41.05
Announcement Date 22/04/20 23/04/21 28/04/22 27/04/23 29/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 187.1 210.4 513.5 5,369 3,557 541.3
EBITDA 1 59.2 47.58 141.2 2,631 1,184 6.737
EBIT 1 42.73 25.91 112.5 2,574 1,095 -53.33
Operating Margin 22.83% 12.31% 21.9% 47.93% 30.79% -9.85%
Earnings before Tax (EBT) 1 55.5 37.86 127.4 2,582 1,075 13.5
Net income 1 48.14 33.88 112.1 2,186 944.7 27.38
Net margin 25.73% 16.1% 21.82% 40.71% 26.56% 5.06%
EPS 2 0.6959 0.4527 1.216 23.74 10.28 0.3100
Free Cash Flow 1 17.18 -114.1 -35.57 1,646 128.6 -561.3
FCF margin 9.18% -54.21% -6.93% 30.67% 3.62% -103.71%
FCF Conversion (EBITDA) 29.02% - - 62.59% 10.87% -
FCF Conversion (Net income) 35.68% - - 75.33% 13.62% -
Dividend per Share - 0.2027 1.014 3.378 - 0.2000
Announcement Date 08/09/19 22/04/20 23/04/21 28/04/22 27/04/23 29/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 63.8 399 383 2,053 1,420 587
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 17.2 -114 -35.6 1,646 129 -561
ROE (net income / shareholders' equity) 25.9% 7.85% 15.9% 122% 29.7% 0.45%
ROA (Net income/ Total Assets) 11.7% 3.26% 8.63% 70.7% 18.1% -0.89%
Assets 1 411.7 1,039 1,298 3,090 5,207 -3,064
Book Value Per Share 2 3.040 7.010 8.070 30.90 37.30 37.60
Cash Flow per Share 2 0.9200 4.590 4.160 12.60 5.850 3.050
Capex 1 42 88.5 172 399 565 413
Capex / Sales 22.45% 42.05% 33.55% 7.43% 15.89% 76.37%
Announcement Date 08/09/19 22/04/20 23/04/21 28/04/22 27/04/23 29/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BEIJING HOTGEN BIOTECH CO., LTD. Stock Beijing Hotgen Biotech Co., Ltd.
-37.34% 32Cr
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.92% 18TCr
MEDTRONIC PLC Stock Medtronic plc
-3.70% 10TCr
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.29% 6.69TCr
CENCORA, INC. Stock Cencora, Inc.
+10.99% 4.67TCr
DEXCOM, INC. Stock DexCom, Inc.
-7.70% 4.51TCr
HOYA CORPORATION Stock Hoya Corporation
+5.82% 4.16TCr
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.96% 3.05TCr
TERUMO CORPORATION Stock Terumo Corporation
+14.00% 2.43TCr
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.63% 2.36TCr
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 688068 Stock
  4. Financials Beijing Hotgen Biotech Co., Ltd.